Try our mobile app

General information

Sistema PJSC FC is a publicly-listed investment company incorporated in Russia. The Company owns a diverse set of public and private companies which it holds in two distinct portfolios: Core assets and Developing assets.
  • Dividend yield for the last twelve months 1.4%
  • Free cash flow yield -57.0% (LTM)
  • Share price is 183.7% higher than minimum and 11.2% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (6.2x vs
    )

Key Financials (Download financials)

Ticker: AFKS
Share price, RUB:  (-0.7%)29.14
year average price 18.42  


year start price 15.98 2023-05-20

min close price 15.20 2023-12-14

max close price 29.34 2024-05-16

current price 29.14 2024-05-18
Common stocks: 9 650 000 000
Dividend Yield:  1.4%
FCF Yield LTM: -57.0%
EV / LTM EBITDA: 6.2x
EV / EBITDA annualized: 9.1x
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 281 201
Net Debt (m RUB): 1 451 048
EV (Enterprise Value): 1 732 249
EBITDA LTM (m RUB): 280 200
EV / LTM EBITDA: 6.2x
Average daily trading volume for the week, RUB mln: 2713.07

Revenue and EBITDA

Quarterly values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

Valuation through assets (as of the end of 2023 q4)

Sistema PJSC FC has stakes in the following companies

Company Ticker Share Cap EBITDA LTM Net Debt
Segezha Group SGZH 72.0% 58 053 9 281 140 530
MTS MTSS 50.3% 528 782 206 662 441 013
OZON OZON 32.4% 963 550
Etalon ETLN 50.1% 38 253 12 738 119 491
Influence at AFKS 639 130 228 681 701 034
mln RUB
 
         Net Debt AFKS 1 451 048
         Net Debt in listed companies 701 034
      Net Debt in not listed companies 750 014
 
         EBITDA LTM AFKS 280 200
         EBITDA LTM in listed companies 228 681
         EBITDA LTM in not listed companies 51 519
      EV evaluation in not listed companies (x5) 257 595
 
      Binnopharm Cap revaluation 41 600
 
   Cap in not listed companies, min -300k -450 819
   Cap in listed companies 639 130
 
AFKS Cap evaluation through assets 339 130
AFKS Cap 281 201
 
Current price discount 17.1%
Historical price discount 8.9%
 
Growth potential (0.912 / 0.829 - 1) +9.9%
chart technology by TradingView
chart technology by TradingView
More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company